Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT)

Anita J. Kumar, MDMS, Phyllis A. Gimotty, PhD, Joel Gelfand, MDMS, Georgina Buck, Jacob M. Rowe, MD, Anthony H Goldstone, MD, Adele Fielding, MB BS, PhD, David I Marks, Mark Litzow, Elisabeth Paietta, PhD, Hillard M. Lazarus, Martin S. Tallman, MD, Selina M. Luger, MD, Alison W. Loren, MDMS

Blood (2014) 124 (21): 208.

https://doi.org/10.1182/blood.V124.21.208.208

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure

Jaimal Kothari, MD, Antonia Ljubic, BSc, Karl S Peggs, MD, Kirsty Thomson, MD, Emma Morris, MD, Andres E. Virchis, MD, Jonathan Lambert, MD, Anthony H Goldstone, MD, David C Linch, MD FMedSci, Kirit M Ardeshna, MD

Blood (2011) 118 (21): 2025.

https://doi.org/10.1182/blood.V118.21.2025.2025

Published: 2011

Journal Articles

Response-Adjusted Transplantation in Primary Resistant and Relapsed Hodgkin Lymphoma

Kirsty Thomson, Irfan Kayani, Kirit M Ardeshna, MD, Emma Morris, MD, Rachael Hough, Anthony H Goldstone, MD, David C Linch, MD FMedSci, Karl S Peggs, MD

Blood (2011) 118 (21): 336.

https://doi.org/10.1182/blood.V118.21.336.336

Published: 2011

Journal Articles

Positive Pre-Transplantation [18-F] FDG-PET Is Not a Barrier to Successful Allograft Outcomes in Chemosensitive Hodgkin Lymphoma

Karl S Peggs, Irfan Kayani, Kirsty Thomson, Emma Morris, MD, Panagiotis Kottaridis, Kirit M Ardeshna, MD, Adele Fielding, Rachael Hough, Anthony H Goldstone, MD, Ronjon Chakraverty, David C Linch, MD FMedSci, Stephen Mackinnon

Blood (2011) 118 (21): 2016.

https://doi.org/10.1182/blood.V118.21.2016.2016

Published: 2011

Journal Articles

Rituximab Purging and Maintenance Improves Progression Free Survival but Not Overall Survival In Patients with Relapsed or Resistant Follicular Lymphoma Prior Receiving An Autologous Transplant

Ruth Pettengell, MD, Norbert Schmitz, MD, Christian Gisselbrecht, MD, Graeme Smith, MD, William N Patton, MD, Bernd Metzner, MD, Dolores Caballero, MD, Herve Tilly, MD, Jan A Walewski, MD, Isabelle Bence-Bruckler, MD, Bik To, MD, Christian H. Geisler, MD, Rik Schots, MD, Eva Kimby, MD, Christian J. Taverna, MD, T. Kozak, MD, Ruzena Uddin, MSci, Carmen Ruiz de Elvira, PhD, Anthony H. Goldstone, MD

Blood (2010) 116 (21): 3567.

https://doi.org/10.1182/blood.V116.21.3567.3567

Published: 2010

Journal Articles

Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.

Adele K. Fielding, MBBS, PhD, Susan M. Richards, PhD, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Selina M. Luger, MD, David I. Marks, MBBS, PhD, Andrew K. McMillan, MBBS, PhD, Jacob M. Rowe, MD, Martin S. Tallman, MD, Anthony H. Goldstone, MD

Blood (2007) 110 (11): 8.

https://doi.org/10.1182/blood.V110.11.8.8

Published: 2007

Journal Articles

Idarubicin and ATRA Is as Effective as MRC Chemotherapy in Patients with Acute Promyelocytic Leukaemia with Lower Toxicity and Resource Usage: Preliminary Results of the MRC AML15 Trial.

Alan K. Burnett, MD, Robert K. Hills, DPhil, David Grimwade, MD, Anthony H. Goldstone, MD, Ann Hunter, MD, Don Milligan, MD, Archie G. Prentice, MD, Nigel H. Russell, MD, Keith Wheatley, DPhil

Blood (2007) 110 (11): 589.

https://doi.org/10.1182/blood.V110.11.589.589

Published: 2007

Journal Articles

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

Michal Sieniawski, MD, Andreas Josting, MD, Carmen Canals, MD, Anthony H. Goldstone, MD, Martin Gramatzki, MD, Didier Blaise, MD, Christian Gisselbrecht, MD, Charles Crawley, MD, Philippe Colombat, MD, Jean-Luc Harousseau, MD, Peter Johnson, MD, Angelo Michele Carella, MD, Anna Sureda, MD, Gerard Socie, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 834.

https://doi.org/10.1182/blood.V110.11.834.834

Published: 2007

Journal Articles

In Adults with Standard-Risk Acute Lymphoblastic Leukemia (ALL) the Greatest Benefit Is Achieved from an Allogeneic Transplant in First Complete Remission (CR) and an Autologous Transplant Is Less Effective Than Conventional Consolidation/Maintenance Chemotherapy: Final Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Jacob M. Rowe, MD, Georgina Buck, PhD, Adele Fielding, MD, Martin S. Tallman, MD, Alan K. Burnett, MD, Raj Chopra, MD, Peter H. Wiernik, MD, Susan M. Richards, PhD, Hillard M. Lazarus, MD, Letizia Foroni, MD, Elisabeth Paietta, PhD, Mark R. Litzow, MD, David Marks, MD, Jill Durrant, MD, Anthony H. Goldstone, MD

Blood (2006) 108 (11): 2.

https://doi.org/10.1182/blood.V108.11.2.2

Published: 2006

Journal Articles

Reduced Intensity Allogeneic Transplantation for Non-Hodgkin’s Lymphoma: Extended Follow-Up of an Alemtuzumab-Containing Regimen.

Kirsty J. Thomson, MD, Emma C. Morris, MD, Don Milligan, MD, Gordon Cook, MD, Jim Cavet, MD, Charles Craddock, MD, Ann Hunter, MD, Steve Schey, MD, Anne Parker, MD, Anthony H. Goldstone, MD, David C. Linch, MD, Karl S. Peggs, MD, Stephen Mackinnon, MD

Blood (2005) 106 (11): 401.

https://doi.org/10.1182/blood.V106.11.401.401

Published: 2005

Journal Articles

The Use of PET Scans To Direct Immunotherapy Following Reduced Intensity Stem Cell Transplants in Adults with Lymphoid Malignancies.

Nichola Cooper, MD, Irit Avivi, MD, Peggs S. Karl, MD, Dan Q. Hart, MD, Kirsty Thomson, MD, Adrian J.C. Bloor, MD, Anthony H. Goldstone, MD, David C. Linch, MD, Peter Ell, MD, J. Bomanji, MD, Stephen Mackinnon, MD

Blood (2005) 106 (11): 5408.

https://doi.org/10.1182/blood.V106.11.5408.5408

Published: 2005

Journal Articles

Modification or Dose or Treatment Duration Has No Impact on Outcome of AML in Older Patients: Preliminary Results of the UK NCRI AML14 Trial.

Alan K. Burnett, MD, Donald W. Milligan, MD, Archie G. Prentice, MB, Anthony H. Goldstone, MD, Mary F. McMullin, MD, Robert K. Hills, PhD, Keith Wheatley, PhD

Blood (2005) 106 (11): 543.

https://doi.org/10.1182/blood.V106.11.543.543

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: No Increase in Relapse with Alemtuzumab-Depleted Grafts.

Kirsty J. Thomson, MD, Karl S. Peggs, MD, Emma C. Morris, MD, Asim Khwaja, MD, David C. Linch, MD, Anthony H. Goldstone, MD, Stephen Mackinnon, MD

Blood (2005) 106 (11): 2053.

https://doi.org/10.1182/blood.V106.11.2053.2053

Published: 2005

Journal Articles

Improved Outcome Following Reduced Intensity Allogeneic Transplantation in Hodgkin’s Lymphoma Relapsing Post-Autologous Transplantation.

Kirsty J. Thomson, MD, Karl S. Peggs, MD, Paul Smith, MSc, Raj Chopra, MD, Jim Cavet, MD, Ann Hunter, MD, Anne Parker, MD, Ruth Pettengell, MD, Don Milligan, MD, Emma C. Morris, MD, Anthony H. Goldstone, MD, David C. Linch, MD, Stephen Mackinnon, MD

Blood (2005) 106 (11): 657.

https://doi.org/10.1182/blood.V106.11.657.657

Published: 2005

Journal Articles

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

Hillard M. Lazarus, MD, Sue M. Richards, Raj Chopra, MD, Mark R. Litzow, MD, Alan K. Burnett, MD, Peter H. Wiernik, MD, Ian M. Franklin, MD, Martin S. Tallman, MD, G. Buck, Jill Durrant, Jacob M. Rowe, MD, Anthony H. Goldstone, MD

Blood (2004) 104 (11): 4484.

https://doi.org/10.1182/blood.V104.11.4484.4484

Published: 2004

Journal Articles

Patients with Lymphoplasmacytic Lymphoma Can Be Salvaged with Autologous Stem Cell Transplantation, Irrespectively of the Number of Previous Treatment Lines. Analysis of 146 Cases from the European Bone Marrow Transplant Registry (EBMT).

Charalampia A. Kyriakou, MD, Anthony H. Goldstone, MD, Anna Sureda, MD, Kwee Yong, PhD, Shirley D’Sa, MD, Goli Taghipour, Carmen Ruiz de Elvira, David C. Linch, MD, PhD, Norbert Schmitz, MD, PhD

Blood (2004) 104 (11): 11.

https://doi.org/10.1182/blood.V104.11.11.11

Published: 2004

Journal Articles

Does All-Transretinoic Acid (ATRA) Have a Role in Non-APL Acute Myeloid Leukaemia?: Results from 1666 Patients in Three MRC Trials.

Alan K. Burnett, MD, Donald Milligan, MD, Robert K. Hills, PhD, Anthony H. Goldstone, MD, Archie G. Prentice, MD, Keith Wheatley, PhD, David C. Webb, MD, Brenda Gibson, MD

Blood (2004) 104 (11): 1794.

https://doi.org/10.1182/blood.V104.11.1794.1794

Published: 2004

Journal Articles

Role of Allogeneic Stem Cell Transplantation in Lymphoplasmacytic Lymphoma. Analysis of 61 Cases from the European Bone Marrow Registry (EBMT).

Charalampia A. Kyriakou, MD, Anthony H. Goldstone, MD, Anna Sureda, MD, Kwee Yong, MD, PhD, Goli Taghipour, Carmen Ruiz de Elvira, David C. Linch, MD, PhD, Stephen Mackinnon, MD, Norbert Schmitz, MD, PhD

Blood (2004) 104 (11): 3326.

https://doi.org/10.1182/blood.V104.11.3326.3326

Published: 2004

Journal Articles

Low Dose Ara-C Versus Hydroxyurea with or without Retinoid in Older Patients Not Considered Fit for Intensive Chemotherapy: The UK NCRI AML14 Trial.

Alan K. Burnett, MD, Donald Milligan, MD, Archie G. Prentice, MD, Anthony H. Goldstone, MD, Mary F. McMullin, MD, Keith Wheatley, PhD

Blood (2004) 104 (11): 872.

https://doi.org/10.1182/blood.V104.11.872.872

Published: 2004

Journal Articles

The Impact of Transplant in AML in 2nd CR: A Prospective Study of 741 in the MRC AML 10 and 12 Trials.

Alan K. Burnett, MD, Robert K. Hills, PhD, Anthony H. Goldstone, MD, Donald Milligan, MD, Archie G. Prentice, MD, Ian Hann, MD, David Webb, MD, Brenda Gibson, MD, Keith Wheatley, PhD

Blood (2004) 104 (11): 620.

https://doi.org/10.1182/blood.V104.11.620.620

Published: 2004

NARROW

Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT)

Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure

Response-Adjusted Transplantation in Primary Resistant and Relapsed Hodgkin Lymphoma

Positive Pre-Transplantation [18-F] FDG-PET Is Not a Barrier to Successful Allograft Outcomes in Chemosensitive Hodgkin Lymphoma

Rituximab Purging and Maintenance Improves Progression Free Survival but Not Overall Survival In Patients with Relapsed or Resistant Follicular Lymphoma Prior Receiving An Autologous Transplant

Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.

Idarubicin and ATRA Is as Effective as MRC Chemotherapy in Patients with Acute Promyelocytic Leukaemia with Lower Toxicity and Resource Usage: Preliminary Results of the MRC AML15 Trial.

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

Reduced Intensity Allogeneic Transplantation for Non-Hodgkin’s Lymphoma: Extended Follow-Up of an Alemtuzumab-Containing Regimen.

The Use of PET Scans To Direct Immunotherapy Following Reduced Intensity Stem Cell Transplants in Adults with Lymphoid Malignancies.

Modification or Dose or Treatment Duration Has No Impact on Outcome of AML in Older Patients: Preliminary Results of the UK NCRI AML14 Trial.

Allogeneic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: No Increase in Relapse with Alemtuzumab-Depleted Grafts.

Improved Outcome Following Reduced Intensity Allogeneic Transplantation in Hodgkin’s Lymphoma Relapsing Post-Autologous Transplantation.

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

Patients with Lymphoplasmacytic Lymphoma Can Be Salvaged with Autologous Stem Cell Transplantation, Irrespectively of the Number of Previous Treatment Lines. Analysis of 146 Cases from the European Bone Marrow Transplant Registry (EBMT).

Does All-Transretinoic Acid (ATRA) Have a Role in Non-APL Acute Myeloid Leukaemia?: Results from 1666 Patients in Three MRC Trials.

Role of Allogeneic Stem Cell Transplantation in Lymphoplasmacytic Lymphoma. Analysis of 61 Cases from the European Bone Marrow Registry (EBMT).

Low Dose Ara-C Versus Hydroxyurea with or without Retinoid in Older Patients Not Considered Fit for Intensive Chemotherapy: The UK NCRI AML14 Trial.

The Impact of Transplant in AML in 2nd CR: A Prospective Study of 741 in the MRC AML 10 and 12 Trials.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only